These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23551828)
1. Drug use evaluation of cefepime in the first affiliated hospital of Bengbu medical college: a retrospective and prospective analysis. Shi Q; Ding F; Sang R; Liu Y; Yuan H; Yu M BMC Infect Dis; 2013 Apr; 13():160. PubMed ID: 23551828 [TBL] [Abstract][Full Text] [Related]
2. Cefepime--assessment of its need at a tertiary care center. Harbarth S; Pittet D; Gabriel V; Garbino J; Lew D J Clin Pharm Ther; 1998 Feb; 23(1):11-7. PubMed ID: 9756106 [TBL] [Abstract][Full Text] [Related]
3. Cefepime and its role in pediatric infections. Shahid SK Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):145-8. PubMed ID: 18673128 [TBL] [Abstract][Full Text] [Related]
4. Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study. Descombes E; Martins F; Hemett OM; Erard V; Chuard C BMC Pharmacol Toxicol; 2016 Feb; 17():4. PubMed ID: 26846675 [TBL] [Abstract][Full Text] [Related]
5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
6. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison. Corapcioglu F; Sarper N; Zengin E Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534 [TBL] [Abstract][Full Text] [Related]
7. Drug utilization study of two generic antibiotics in a tertiary hospital in Bogotá. López JJ; Cortázar Y; Acosta Á; Vargas-Peláez CM; Rossi F Biomedica; 2018 Sep; 38(3):398-406. PubMed ID: 30335245 [TBL] [Abstract][Full Text] [Related]
8. Implementing extended-infusion cefepime as standard of care in a children's hospital: a prospective descriptive study. Nichols KR; Karmire LC; Cox EG; Kays MB; Knoderer CA Ann Pharmacother; 2015 Apr; 49(4):419-26. PubMed ID: 25614528 [TBL] [Abstract][Full Text] [Related]
9. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010. Levy ER; Swami S; Dubois SG; Wendt R; Banerjee R Infect Control Hosp Epidemiol; 2012 Apr; 33(4):346-53. PubMed ID: 22418629 [TBL] [Abstract][Full Text] [Related]
11. The safety of cefepime and ceftazidime in pediatric oncology patients. Hoffman JM; Frediani J; Herr M; Flynn PM; Adderson EE Pediatr Blood Cancer; 2013 May; 60(5):806-9. PubMed ID: 23382054 [TBL] [Abstract][Full Text] [Related]
12. Drug use evaluation of cefepime at Khartoum North Teaching Hospital in Sudan. Obeid WMN; Abdoon IH; Osman B; Osman WJA; Suliman HM; Mohamed EM; Mothana RAA Int J Clin Pract; 2021 Apr; 75(4):e13882. PubMed ID: 33277753 [TBL] [Abstract][Full Text] [Related]
13. Cefepime: a reappraisal in an era of increasing antimicrobial resistance. Endimiani A; Perez F; Bonomo RA Expert Rev Anti Infect Ther; 2008 Dec; 6(6):805-24. PubMed ID: 19053894 [TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection. Barie PS; Rotstein OD; Dellinger EP; Grasela TH; Walawander CA Surg Infect (Larchmt); 2004; 5(3):269-80. PubMed ID: 15684798 [TBL] [Abstract][Full Text] [Related]
15. Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study. Huwyler T; Lenggenhager L; Abbas M; Ing Lorenzini K; Hughes S; Huttner B; Karmime A; Uçkay I; von Dach E; Lescuyer P; Harbarth S; Huttner A Clin Microbiol Infect; 2017 Jul; 23(7):454-459. PubMed ID: 28111294 [TBL] [Abstract][Full Text] [Related]
16. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Chopra T; Marchaim D; Veltman J; Johnson P; Zhao JJ; Tansek R; Hatahet D; Chaudhry K; Pogue JM; Rahbar H; Chen TY; Truong T; Rodriguez V; Ellsworth J; Bernabela L; Bhargava A; Yousuf A; Alangaden G; Kaye KS Antimicrob Agents Chemother; 2012 Jul; 56(7):3936-42. PubMed ID: 22547616 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of cefepime in the treatment of serious bacterial infections in hospitalized adult patients. Sheng WH; Wang JT; Chang SC J Microbiol Immunol Infect; 2000 Jun; 33(2):109-14. PubMed ID: 10917881 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem. Tanaka A; Takechi K; Watanabe S; Tanaka M; Suemaru K; Araki H Int J Clin Pharm; 2013 Oct; 35(5):683-7. PubMed ID: 23733559 [TBL] [Abstract][Full Text] [Related]
19. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients. Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896 [TBL] [Abstract][Full Text] [Related]
20. Teaching exercise of drug utilization by medical students. Das BP; Sethi A; Nutan K; Gunjan JNMA J Nepal Med Assoc; 2005; 44(160):160-4. PubMed ID: 18380068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]